Therapeutic approaches of nutraceuticals in the prevention of Alzheimer's disease

• Published in: Journal of food biochemistry Vol. 46; no. 12; pp. e14426 - n/a
• Main Authors: Pandey, Surya Nath, Singh, Gurfateh, Semwal, Bhupesh Chander, Gupta, Gaurav, Alharbi, Khalid Saad, Almalki, Waleed Hassan, Albratty, Mohammed, Najmi, Asim, Meraya, Abdulkarim M.
• Format: Journal Article
• Language: English
• Published: United States 01.12.2022
• Subjects: Alzheimer Disease - drug therapy; Alzheimer Disease - prevention & control; Alzheimer's disease; Anti-Inflammatory Agents; Antioxidants - therapeutic use; Dietary Supplements; flavonoid; Humans; nutraceuticals; oxidative stress; probiotics; Prospective Studies; flavonoid; Alzheimer's disease; nutraceuticals; oxidative stress; probiotics
• ISSN: 0145-8884; 1745-4514
• DOI: 10.1111/jfbc.14426

Alzheimer's disease (AD) is a neurological illness that causes memory loss over time. Currently, available pharmaceutical medicines and products are limited, and they have side effects at a higher price. Researchers and scientists have observed significant effects of nutraceuticals. Various preclinical and clinical studies were investigated for the Anti‐Alzheimer's activity of nutraceuticals. The increasing ability of the pathogenesis of AD has led to the analysis of novel therapeutic targets, including the pathophysiological mechanisms and distinct cascades. So, current improvement will show the most adequate and prominent nutraceuticals and suggested concise mechanisms involving autophagy regulation, anti‐inflammatory, antioxidant, mitochondrial homeostasis, and others. The effects of nutraceuticals cannot be ignored; it is important to investigate high‐quality clinical trials. Given the potential of nutraceuticals to battle AD as multi‐targeted therapies, it's vital to evaluate them as viable lead compounds for drug discovery and development. To the best of the authors ‘knowledge, modification of blood–brain barrier permeability, bioavailability, and aspects of randomized clinical trials should be considered in prospective investigations. Practical applications Advancements in molecular diagnostic and fundamentals have implemented particular usefulness for drug evaluation. An excess of experimental knowledge occurs regarding the effect of nutraceuticals on AD. There are various preclinical and clinical studies that have been done on nutraceuticals. In addition, various substitute inhibit and enhance some pathophysiological levels associated with AD. Nutraceuticals are easily available and have fewer side effects with cost‐effective advantages. However, further investigations and clinical trials are required to encourage its effect on disease. Alzheimer's disease (AD) is a neurological illness that causes memory loss over time. Preclinical and clinical studies were investigated for the Anti‐Alzheimer's activity of nutraceuticals. This review showed therapeutic approaches of Nutraceuticals in the prevention of AD.